Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
Chubb
US Army
Queensland Health
Farmers Insurance
Medtronic
McKesson
Accenture

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012674

« Back to Dashboard

NDA 012674 describes HEXADROL, which is a drug marketed by Aspen Global Inc and is included in three NDAs. Additional details are available on the HEXADROL profile page.

The generic ingredient in HEXADROL is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Summary for 012674
Medical Subject Heading (MeSH) Categories for 012674

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:ELIXIR;ORALStrength0.5MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
US Department of Justice
Moodys
Fuji
Deloitte
Teva
Accenture
Chubb
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.